Lataa...
Targeted anti-vascular therapies for ovarian cancer: current evidence
Ovarian cancer presents at advanced stage in around 75% of women, and despite improvements in treatments such as chemotherapy, the 5-year survival from the disease in women diagnosed between 1996 and 1999 in England and Wales was only 36%. Over 80% of patients with advanced ovarian cancer will relap...
Tallennettuna:
| Päätekijät: | , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3566823/ https://ncbi.nlm.nih.gov/pubmed/23385789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2012.541 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|